Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Nafarelin (Synarel) Peptide
Intranasal GnRH agonist for endometriosis and central precocious puberty.
What is Nafarelin (Synarel)?
Nafarelin (Synarel) is a gnrh agonist · endocrine peptide studied for endometriosis and central precocious puberty. Below is an educational overview of Nafarelin (Synarel) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Synarel
Endometriosis and central precocious puberty.
A nasal spray version of a GnRH agonist that lowers sex hormones to ease endometriosis pain or pause early puberty.
- •Hot flashes
- •Vaginal dryness
- •Decreased libido
- •Headache
- •Nasal irritation
- •Bone density loss with prolonged use
- •Mood changes
- •Initial hormone flare
- •Pregnancy
- •Undiagnosed abnormal vaginal bleeding
- •Known hypersensitivity to GnRH analogs
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Nafarelin (Synarel) Mechanism of Action
Decapeptide GnRH agonist administered intranasally; sustained receptor occupancy downregulates pituitary GnRH receptors, suppressing gonadotropin and sex steroid output.
Nafarelin (Synarel) Research Areas & Benefits
Nafarelin (Synarel) Dosage & Common Research Protocols
200 mcg per spray; one spray in each nostril twice daily for endometriosis.
Protocols summarized for educational reference from published research. Not dosing guidance.
Nafarelin (Synarel) Studies & Cited Research
Nafarelin for endometriosis
Comparable pain and lesion reduction to danazol with different side-effect profile.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Nafarelin (Synarel) Side Effects & Safety Considerations
- •FDA-approved.
- •Hypoestrogenic symptoms; limit treatment course for bone health.
Common questions about Nafarelin (Synarel)
More Hormonal peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.